SciBase continues US expansion, on-boards Several US Dermatology Practices that Specialize in Skin Cancer Detection

"To date, evaluating atypical moles at point-of-care to assess and guide biopsy decisions remains challenging, even for experienced dermoscopists. Early melanomas and even some invasive melanomas can have very few morphologic features, which make it challenging to assess at point-of-care. The Nevisense tests is non-invasive and provides us with important cellular data from below the skin surface before we make our biopsy decision, enabling improved atypical mole management for our patients," said Dr. Alison Z. Young, dermatologist and dermatopathologist, and owner of Young Dermatology in Seattle, Washington.

STOCKHOLM, 30/01/2025 (informazione.news - comunicati stampa - salute e benessere)

" " said Dr. Alison Z. Young , dermatologist and dermatopathologist, and owner of Young Dermatology in Seattle, Washington .

" " said Pia Renaudin , CEO of SciBase.

Pia Renaudin , CEO, tel. +46732069802, e-mail: pia.renaudin@scibase.com

Carnegie Investment Bank AB (publ)
Phone: +46 (0)73 856 42 65
E-mail: certifiedadviser@carnegie.se

This information was brought to you by Cision http://news.cision.com.

https://news.cision.com/scibase/r/scibase-continues-us-expansion--on-boards-several-us-dermatology-practices-that-specialize-in-skin-c,c4098412

The following files are available for download:

 

View original content:https://www.prnewswire.co.uk/news-releases/scibase-continues-us-expansion-on-boards-several-us-dermatology-practices-that-specialize-in-skin-cancer-detection-302364371.html